Copyright © 2001 by the European Society of Cardiology.
Editorials
Early atrial defibrillation; a stitch in time saves nine or haste makes waste?
a Departments of Medicine, Physiology, and Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama, U.S.A.
b Department of Cardiology, Charite Hospital, Berlin, Germany
References
- Vardas PE, Manios EG, Kanoupakis EM, Dermitzaki DN, Mavrakis HE, Kallergis EM. Atrial defibrillation threshold in humans minutes after atrial fibrillation induction. A stitch in time saves nine. Eur Heart J. 2001;22:16131617
[Abstract/Free Full Text] - Levy S, Ricard P, Lau C. Multicenter low energy transvenous atrial defibrillation (XAD) trial. J Am Coll Cardiol. 1997;29:750755[Abstract]
- Ammer R, Lehmann G, Plewan A, Puetter K, Alt E. Marked reduction in atrial defibrillation thresholds with repeated internal cardioversion. J Am Coll Cardiol. 1999;34:15691576
[Abstract/Free Full Text] - Fotuhi PC, Cooper RAS, Sreenan CM, Rollins DL, Smith WM, Ideker RE. Can early timed internal atrial defibrillation shocks reduce the atrial defibrillation threshold? PACE. 1999;22:11791185
- Ravelli F, Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation. 1997;96:16861695
[Abstract/Free Full Text] - Hillsley RE, Wharton JM, Cates AW, Wolf PD, Ideker RE. Why do some patients have high defibrillation thresholds at defibrillator implantation? Answers from basic research. PACE. 1994;17:222239
- Power JM, Beacom GA, Alferness CA, Raman J, Farish SJ, Tonkin AM. Effects of left atrial dilatation on the endocardial atrial defibrillation threshold: a study in an ovine model of pacing induced dilated cardiomyopathy. PACE. 1998;21:15951600
- Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats. Circulation. 1995;92:19541968
[Abstract/Free Full Text] - Pinski SL, Fahy GJ. Implantable cardioverter-defibrillators. Am J Med. 1999;106:446458[CrossRef][ISI][Medline]
- Murgatroyd FD, Slade AK, Sopher SM, Rowland E, Ward DE, Camm AJ. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol. 1995;25:13471353[Abstract]
- Jung J, Heisel A, Fries R, Kollner V. Tolerability of internal low-energy shock strengths currently needed for endocardial atrial cardioversion. Am J Cardiol. 1997;80:14891490[CrossRef][ISI][Medline]
- Strobel JS, Kenknight BH, Rollins DL, Smith WM, Ideker RE. The effects of ventricular fibrillation duration and site of initiation on the defibrillation threshold during early ventricular fibrillation. J Am Coll Cardiol. 1998;32:521527
[Abstract/Free Full Text] - Yamashita T, Murakawa Y, Sezaki K. Circadian variation of paroxysmal atrial fibrillation. Circulation. 1997;96:15371541
[Abstract/Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||